Kamada (NASDAQ:KMDA – Get Rating) and PyroGenesis Canada (NASDAQ:PYR – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability and risk. Analyst Ratings This is a breakdown of recent ratings and […]
Kamada Ltd. (NASDAQ:KMDA – Get Rating) – Zacks Small Cap decreased their FY2023 earnings per share estimates for shares of Kamada in a report released on Monday, March 20th. Zacks Small Cap analyst D. Bautz now expects that the biotechnology company will post earnings per share of $0.10 for the year, down from their previous […]
StockNews.com began coverage on shares of Kamada (NASDAQ:KMDA – Get Rating) in a research report issued on Sunday. The firm set a “buy” rating on the biotechnology company’s stock. Separately, Zacks Investment Research cut shares of Kamada from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 24th. NASDAQ KMDA […]
Kamada (NASDAQ:KMDA – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a report released on Tuesday, Zacks.com reports. According to Zacks, “Kamada Ltd. is a biopharmaceutical company. It develops, produces and markets therapeutics based on chromatographic purification technology. The company offers bio-therapeutics for specialty proteins, […]
Kamada (NASDAQ:KMDA – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Friday, Zacks.com reports. According to Zacks, “Kamada Ltd. is a biopharmaceutical company. It develops, produces and markets therapeutics based on chromatographic purification technology. The company offers bio-therapeutics for specialty […]